The global market for antiepileptic drugs (AEDs) is on an upward trajectory, with substantial opportunities for growth through 2035. The industry, which is projected to reach a value of USD 30.0 billion by 2035, is expected to grow at a compound annual growth rate (CAGR) of 4.3% over the next decade. As manufacturers look to expand their market share, understanding the dynamics of...